We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.86%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$23M
(-0.77%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
462
New
54
Increased
149
Reduced
151
Closed
64
Avg Time Held
1.1
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$51.1M |
| 2 |
AbbVie
ABBV
|
+$36.3M |
| 3 |
Juniper Networks
JNPR
|
+$34.2M |
| 4 |
MSCI
MSCI
|
+$34.2M |
| 5 |
Darden Restaurants
DRI
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
Union Pacific
UNP
|
+$39.8M |
| 3 |
VeriSign
VRSN
|
+$37.8M |
| 4 |
Jack Henry & Associates
JKHY
|
+$36.2M |
| 5 |
Booz Allen Hamilton
BAH
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20% |
| 2 | Healthcare | 19.75% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Industrials | 11.13% |
| 5 | Financials | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
HNI Corp
HNI
$3.4B
| $1.82M | 0.06% |
35,726
+29,000
| +431% | +$1.5M |
2014 Q2
4 quarters
|
|
152
Hackett Group
HCKT
$290M
| $1.75M | 0.06% |
129,940
-1,270
| -1% | -$13.8K |
2013 Q3
7 quarters
|
|
153
Xencor
XNCR
$1.78B
| $1.72M | 0.06% |
78,400
+1,300
| +2% | +$22.2K |
2015 Q1
1 quarter
|
|
|
ADMS
154
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.72M | 0.06% |
65,650
+1,200
| +2% | +$23.3K |
2015 Q1
1 quarter
|
|
|
PES
155
DELISTED
Pioneer Energy Services Corp.
PES
| $1.61M | 0.05% |
253,860
+4,670
| +2% | +$32K |
2014 Q3
3 quarters
|
|
156
DELISTED
Denny's
DENN
| $1.58M | 0.05% |
+136,120
| New | +$1.52M |
2015 Q2
0 quarters
|
|
157
Opko Health
OPK
$1.2B
| $1.57M | 0.05% |
97,570
+1,690
| +2% | +$26.3K |
2015 Q1
1 quarter
|
|
158
Agenus
AGEN
$302M
| $1.48M | 0.05% |
+8,753
| New | +$1.24M |
2015 Q2
0 quarters
|
|
|
GNCA
159
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.43M | 0.05% |
+13,004
| New | +$1.21M |
2015 Q2
0 quarters
|
|
|
AXAS
160
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.42M | 0.05% |
24,043
+18,896
| +367% | +$1.23M |
2013 Q3
7 quarters
|
|
161
Tvardi Therapeutics
TVRD
$14.3M
| $1.39M | 0.05% |
+3,171
| New | +$1.23M |
2015 Q2
0 quarters
|
|
|
TESO
162
DELISTED
Tesco Corp
TESO
| $1.34M | 0.05% |
123,370
+2,290
| +2% | +$27.5K |
2014 Q4
2 quarters
|
|
163
DELISTED
Immunogen Inc
IMGN
| $1.34M | 0.05% |
92,950
+1,790
| +2% | +$19.7K |
2014 Q3
3 quarters
|
|
164
Inovio Pharmaceuticals
INO
$108M
| $1.22M | 0.04% |
12,497
+250
| +2% | +$26.7K |
2014 Q2
4 quarters
|
|
165
DELISTED
Surmodics
SRDX
| $1.22M | 0.04% |
52,000
+800
| +2% | +$20.1K |
2014 Q4
2 quarters
|
|
166
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.15M | 0.04% |
52,500
+1,100
| +2% | +$22.2K |
2015 Q1
1 quarter
|
|
167
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.14M | 0.04% |
+124,393
| New | +$1.2M |
2015 Q2
0 quarters
|
|
168
DELISTED
Xoma
XOMA
| $1.12M | 0.04% |
14,437
+279
| +2% | +$20.1K |
2014 Q2
4 quarters
|
|
|
FPRX
169
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $990K | 0.03% |
39,850
+600
| +2% | +$13.4K |
2015 Q1
1 quarter
|
|
|
NTUS
170
DELISTED
Natus Medical Inc
NTUS
| $940K | 0.03% |
22,080
+390
| +2% | +$15.5K |
2014 Q4
2 quarters
|
|
171
Usana Health Sciences
USNA
$284M
| $932K | 0.03% |
13,640
+380
| +3% | +$24.1K |
2014 Q4
2 quarters
|
|
|
RPXC
172
DELISTED
RPX Corporation
RPXC
| $930K | 0.03% |
55,010
+1,100
| +2% | +$17.2K |
2015 Q1
1 quarter
|
|
|
SCAI
173
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $909K | 0.03% |
23,690
+400
| +2% | +$15.2K |
2014 Q4
2 quarters
|
|
174
Ironwood Pharmaceuticals
IRWD
$623M
| $899K | 0.03% |
88,994
-8,823
| -9% | -$103K |
2015 Q1
1 quarter
|
|
175
BGC Group
BGC
$5.41B
| $884K | 0.03% |
157,024
+3,095
| +2% | +$18.7K |
2014 Q4
2 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Smith Group Asset Management held 462 positions worth $2.97B, down 0.77% from $2.99B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Smith Group Asset Management's Q2 2015 filing shows 54 new, 149 increased, 151 reduced and 64 closed positions. Its largest new stake was Juniper Networks: 1,304,200 shares worth $33.9M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Smith Group Asset Management's largest Q2 2015 buy was Juniper Networks: 1,304,200 shares worth $33.9M.
- Smith Group Asset Management added most to General Dynamics in Q2 2015, an estimated $51.1M increase.
- Smith Group Asset Management's biggest Q2 2015 reduction was Intercontinental Exchange, cutting an estimated $28.9M.
- Smith Group Asset Management fully exited Celgene Corp in Q2 2015, selling an estimated $46.5M.
- Smith Group Asset Management's ten largest holdings make up 28% of its $2.97B portfolio in Q2 2015.
- Smith Group Asset Management opened 54 new positions and closed 64 in Q2 2015.
- Smith Group Asset Management's portfolio value fell 0.77% quarter-over-quarter to $2.97B.
Based on Smith Group Asset Management's 13F filing for Q2 2015, filed 29 Jul 2015.